Fda approves first ngs-based companion diagnostic for ret fusion-positive non-small cell lung cancer

Fda approves first ngs-based companion diagnostic for ret fusion-positive non-small cell lung cancer.thermo fisher scientific - companion diagnostic approval expands clinical utility of oncomine dx target test to identify candidates for gavreto.thermo fisher scientific - to update oncomine dx target test to enable it to report ret fusions in u.s. before end of year.
TMO Ratings Summary
TMO Quant Ranking